USPTO serial 79262220
INDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 16, 2020
- Examiner
- HANSRAJH, KETON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with INDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*
Plus Government fees of $2,550
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lynn E. Rzonca
Lynn E. Rzonca Ballard Spahr LLP1735 Market Street, 51st FloorPhiladelphia, PA 19103-7599UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological reagents and substances for industrial and scientific purposes and laboratory analysis, other than in vivo use; biochemicals for scientific and research use, namely, for sample preparation, modification and manipulation of cells and for labeling, separation, isolation, purification, amplification and analysis of natural and synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; biochemicals, namely, small molecular chemicals for scientific or research use; laboratory chemicals, namely, small molecular chemicals used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Chemicals and biochemical preparations used in industry, in particular, chemical and biochemical substances for molecular biological, biochemical and immunological laboratory testing and analysis, other than for medical or veterinary purposes; biochemical reagent kits comprising biochemical reagents for scientific and research use, namely, for sample preparation, modification and manipulation of samples and cells and for labeling, separation, isolation, purification, amplification and analysis of natural and synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, namely, nucleic acids from biological or biochemical sample substances, none of the foregoing for medical or veterinary use; kits for multiplex polymerase chain reaction (PCR) tests comprised of DNA primers for amplifying DNA and RNA loci | ACTIVE | — |
| 005 | Pharmaceutical medical products for treating infections; veterinary medical products, namely, vaccines; medical products for medical healthcare purposes, namely, reagents; diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely, diagnostic agents for medical and veterinary in-vitro diagnostics; diagnostic agents for medical and veterinary purposes, namely, biological diagnostic agents for testing diseases in cattle, pigs, and other animals; kits comprised of reagents, oligonucleotides, antibodies, in-vitro diagnostic reagents and control reagents all for medical purposes, sold as a unit for medical purposes; diagnostic test kits comprised of testing equipment in the nature of biomolecules, namely, oligonucleotides, primers and probes for DNA and RNA biomarker testing and DNA and RNA infectious disease testing for medical, veterinary, and dental purposes; products for medical and veterinary medical purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for labelling, separation, isolation, purification, amplification and analysis of natural and synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, namely, reagents for medical use, namely, for sample preparation, modification and manipulation of cells, all for medical use; in vitro diagnostic preparations for medical purposes; diagnostic disease testing kits comprised of medical diagnostic reagents, buffers for medical and veterinary purposes; diagnostic disease testing kits comprised of reagents, oligonucleotides, antibodies, in-vitro diagnostic preparations, and control reagents all for medical and veterinary use, sold as a unit for medical and veterinary use; test strips for medical use, namely, for diagnosing infectious diseases | ACTIVE | — |
| 009 | Molecular biological and immunological test systems comprised of apparatus and instruments, namely, laboratory devices for detecting DNA and RNA sequences and for extraction, isolation and purification and detection of nucleic acids and proteins; kits for multiplex polymerase chain reaction (PCR) tests comprised of diagnostic devices for identifying biological and biochemical samples, sequencing apparatus for the purpose of detecting DNA and RNA sequences in polymerase chain reaction (PCR) cyclers and also including associated computer hardware and downloadable software for identifying infectious diseases, all sold for scientific research purposes; scientific apparatus and instruments, namely, PCR cyclers for detecting DNA and RNA sequences | ACTIVE | — |
| 010 | Medical and veterinary diagnostic apparatus and instruments, namely, DNA and RNA analyzers; medical apparatus and instruments, namely, medical apparatus for diagnostic testing and analyzing biological samples in particular containing bacteria or viruses | ACTIVE | — |
| 042 | Scientific laboratory analysis services, namely, molecular biological, biochemical and immunological analysis, namely, conducting molecular biological, biochemical and immunological analysis for testing diseases in cattle, pigs and other animals; scientific and technological services, namely, DNA and RNA based detection of infectious diseases in animals in the field of biochemistry, molecular biology, biology and chemistry; scientific research for medical purposes in the field of infectious diseases; services for screening personal samples of antibodies or antigens for scientific, DNA and RNA research purposes; blood analysis services for detecting and measuring selected antibodies or antigens in blood samples from animals | ACTIVE | — |
| 044 | Information services, namely providing veterinary pharmaceuticals information; providing information relating to veterinary health namely infectious diseases of animals; veterinary consultations provided via telephone and email; medical analysis services for diagnostic and treatment purposes provided by medical laboratories relating to the treatment of animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INDICAL BIOSCIENCE GmbH
- Other trademarks owned by INDICAL BIOSCIENCE GmbH
- Other trademarks owned by INDICAL BIOSCIENCE GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named INDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 25, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 5, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 5, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 16, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 16, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 31, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 11, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 27, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 27, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 23, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 8, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 8, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 17, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 16, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 4, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |